These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4091648)

  • 21. The pharmacokinetics of pyridostigmine and 3-hydroxy-N-methylpyridinium in the rat: dose-dependent effects after portal vein administration.
    Barber HE; Bourne GR; Calvey TN; Muir KT
    Br J Pharmacol; 1975 Nov; 55(3):335-41. PubMed ID: 173444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rapid and equivalent systemic bioavailability of the antidotes HI-6 and dicobalt edetate via the intraosseous and intravenous routes.
    Hill SL; Thomas SH; Flecknell PA; Thomas AA; Morris CM; Henderson D; Dunn M; Blain PG
    Emerg Med J; 2015 Aug; 32(8):626-31. PubMed ID: 25414476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of delta9-tetrahydrocannabinol in dogs.
    Garrett ER; Hunt CA
    J Pharm Sci; 1977 Mar; 66(3):395-407. PubMed ID: 845807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HI-6 therapy and the acute phase response in the rat.
    Ivanović-Matić S; Poznanović G
    Toxicology; 1996 Jan; 106(1-3):11-7. PubMed ID: 8571381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning.
    Worek F; Kleine A; Szinicz L
    Hum Exp Toxicol; 1995 Aug; 14(8):634-42. PubMed ID: 7576830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of besulpamide in rats and dogs.
    Esteve J; Martínez L; Roser R; Sagarra R
    Methods Find Exp Clin Pharmacol; 1987 Feb; 9(2):121-6. PubMed ID: 3586769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Left ventricular mechanical consequences of dihydropyridine calcium channel modulation in conscious and anesthetized chronically instrumented dogs.
    Pagel PS; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Jul; 81(1):190-208. PubMed ID: 7519000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
    Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of laudanosine in dogs.
    Hennis PJ; Fahey MR; Canfell PC; Shi WZ; Miller RD
    Anesthesiology; 1986 Jul; 65(1):56-60. PubMed ID: 3729058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
    Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
    Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupivacaine disposition and pharmacologic effects after intravenous and epidural administrations in dogs.
    Franquelo C; Toledo A; Manubens J; Cristòfol C; Arboix M
    Am J Vet Res; 1995 Aug; 56(8):1087-91. PubMed ID: 8533982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiorespiratory effects of a 5HT2 antagonist (R51703) in awake and anesthetized dogs.
    Doherty TJ; McDonell WN; Dyson DH; Black WD
    Can J Vet Res; 1996 Jul; 60(3):172-8. PubMed ID: 8809379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oxime HGG-12 as a muscarinic acetylcholine receptor antagonist without intrinsic activity in cardiac membranes.
    Reithmann C; Berger HJ; Hilf G; Werdan K
    Arch Toxicol; 1991; 65(6):518-23. PubMed ID: 1929874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levosimendan (OR-1259), a myofilament calcium sensitizer, enhances myocardial contractility but does not alter isovolumic relaxation in conscious and anesthetized dogs.
    Pagel PS; Harkin CP; Hettrick DA; Warltier DC
    Anesthesiology; 1994 Oct; 81(4):974-87. PubMed ID: 7943849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
    Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative toxicokinetics of MMB4 DMS in rats, rabbits, dogs, and monkeys following single and repeated intramuscular administration.
    Hong SP; Gibbs ST; Kobs DJ; Hawk MA; Croutch CR; Osheroff MR; Johnson JD; Burback BL
    Int J Toxicol; 2013; 32(4 Suppl):38S-48S. PubMed ID: 23929448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral kinetics and bioavailability of the cholinesterase reactivator HI-6 after administration of 2 different formulations of tablets to dogs.
    Maksimović M; Jovanović D; Kovacević V; Bokonjić D
    Toxicol Lett; 1987 Nov; 39(1):85-91. PubMed ID: 3672559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics and extra-hepatic clearance of remifentanil, a short acting opioid agonist, in male beagle dogs during constant rate infusions.
    Chism JP; Rickert DE
    Drug Metab Dispos; 1996 Jan; 24(1):34-40. PubMed ID: 8825188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of single or repeated HI-6 treatment following soman poisoning in guinea pigs and marmoset monkeys.
    Busker RW; Zijlstra JJ; Philippens IH; Groen B; Melchers BP
    Toxicology; 1996 Sep; 112(3):183-94. PubMed ID: 8845039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immediate hemodynamic effect of pharmacological doses of methylprednisolone in dogs, and the influence of speed of injection.
    Husum B; Palm T; Andersen K; Vejlsted H
    Acta Anaesthesiol Scand; 1980; 24(1):61-4. PubMed ID: 7376806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.